Scholarly Index
Mafalda Oliveira
Universidade Federal de Minas Gerais; 12,348 total citations; 357 total publications; best world rank #18
Universidade Federal de Minas Gerais
12,348Total citations
357Total publications
47H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Advanced Breast Cancer Therapies | Lifetime | 209 | BR 2 | 98.26 |
| Cancer Treatment and Pharmacology | Lifetime | 730 | BR 4 | 98.07 |
| HER2/EGFR in Cancer Research | Lifetime | 583 | BR 3 | 97.64 |
| PI3K/AKT/mTOR signaling in cancer | Lifetime | 640 | BR 1 | 95.45 |
| Advanced Breast Cancer Therapies | 2021-2025 | 21 | BR 1 | 99.53 |
| Cancer Treatment and Pharmacology | 2021-2025 | 26 | BR 1 | 99.49 |
| HER2/EGFR in Cancer Research | 2021-2025 | 42 | BR 2 | 99.24 |
| Breast Cancer Treatment Studies | 2021-2025 | 83 | BR 2 | 98.86 |
| PI3K/AKT/mTOR signaling in cancer | 2021-2025 | 18 | BR 1 | 96.56 |
| Estrogen and related hormone effects | 2021-2025 | 72 | BR 1 | 94.22 |
| Lung Cancer Research Studies | 2021-2025 | 556 | BR 2 | 93.77 |
| PARP inhibition in cancer therapy | 2021-2025 | 282 | BR 3 | 91.50 |
| Cancer-related Molecular Pathways | 2021-2025 | 244 | BR 3 | 88.83 |
| Brain Metastases and Treatment | 2021-2025 | 945 | BR 1 | 81.78 |